Taipei Prison
Taoyuan, Taiwan
NCT Number: NCT00767975
LTBI Treatment is effective in prison
Looking for future studies?
Notify MeMale
Interventional
Phase 3
Taoyuan, Taiwan
LTBI treatment will be conducted in a prison with either isoniazid or rifampin
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
isoniazid 300mg/tab 1 tab qd, 6 months (the other treatment arm is rifampin)
rifampin 300mg/capsule 2 caps qd, 4 months (the other treatment arm is isoniazid)
Time frame: 1.5 year
Time frame: 3 year
Looking for future studies?
Notify MeNational Taiwan University Hospital
Other
Acronym: LTBI_prison
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04121026
Actinomycetales Infections, Bacterial Infections
Abidjan, Côte d’Ivoire
View Trial DetailsNCT04618198
Actinomycetales Infections, Bacterial Infections
Sanya Juu, Tanzania
View Trial DetailsNCT04926922
Actinomycetales Infections, Bacterial Infections
Bethesda, Maryland, United States
View Trial DetailsNCT02563327
Actinomycetales Infections, Bacterial Infections
Kampala, Uganda
View Trial Details